Nonadherence in hypertension: how to develop and implement chemical adherence testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - Am Heart Assoc
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - Am Heart Assoc
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - Hypertension, 2022 - hal.science
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

[PDF][PDF] Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - dial.uclouvain.be
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - 2021 - figshare.le.ac.uk
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.

D Lane, A Lawson, A Burns, M Azizi… - … (Dallas, Tex.: 1979), 2021 - europepmc.org
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

[PDF][PDF] Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - scholar.archive.org
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

[PDF][PDF] Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - researchgate.net
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in hypertension: how to develop and implement chemical adherence testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2022 - wrap.warwick.ac.uk
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

D Lane, A Lawson, A Burns, M Azizi, M Burnier… - …, 2021 - ingentaconnect.com
Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …